GENEWATCH
 
Volume 30 Issue 1
 
 
Volume 30 Issue 1
CRISPR & Gene Drives
Jan-Mar 2017
 
CRISPR Will Never Be Good Enough to Improve People
By Stuart Newman
 
The Social and Political Dangers of Human Germline Interventions
By Marcy Darnovsky, Elliot Hosman
 
Gene Drives: A Scientific Case for a Complete and Perpetual Ban
By Jonathan Latham
 
Gene Drive and Collective Oversight
By Kevin Esvelt
 
Sterile Insect Techniques, GE Mosquitoes and Gene Drives
By Jaydee Hanson
 
Letter: No Place for Gene Drives in Conservation
 
In Memoriam: Ruth Hubbard
By Sheldon Krimsky
 
Guest Editor's Note
By Andrew Kimbrell
 
 
Search: GeneWatch
 
 
 
The Gene Myths series features incisive, succinct articles by leading scientists disputing the exaggerations and misrepresentations of the power of genes.
 
View Project
 
 
Rapid developments in biotechnology over the last two decades have enabled corporations and scientists to alter nature's handiwork for commercial profit. The patent, a tool originally created to insure that inventors could share in the financial returns and benefits deriving from the use of their nventions, has become the primary mechanism through which the private sector advances its claims to ownership over genes, proteins, and entire organisms.
 
View Project
 
 
Tools
PAGE TOOLS
 
 
 
 
ON THE WEB